Skip to main content
. Author manuscript; available in PMC: 2016 Dec 28.
Published in final edited form as: J Control Release. 2015 Sep 25;220(0 0):715–726. doi: 10.1016/j.jconrel.2015.09.040

Figure 5.

Figure 5

Diagnostic magnetic resonance profiling of human tumor cell lines, fibroblasts, and leukocytes using a pretargeted approach in vitro. The cells were labeled using various trans-cyclooctene (TCO)-conjugated antibodies followed by tetrazine-modified magneto-fluorescent nanoparticles (Tz-MFNPs) prior to the measurement of the transverse relaxation rate (R2). Figure reprinted with permission from Haun et al. [95].